Overview
FDA and USPTO have initiated collaboration efforts following the issuance of Executive Order No. 14036, Promoting Competition in the American Economy, encouraging coordination among agencies with overlapping jurisdiction over industries. Earlier this year a joint USPTO-FDA Public Listening Session on Collaboration Initiatives was held to obtain public input on the PTO’s proposed initiatives to foster coordination between the agencies, enhance meaningful innovation in medical product development, and support a competitive marketplace to promote product access and affordability to the public. Panelists will discuss concerns and suggestions raised at this forum and opine on the changing landscape of innovation for industry and progress towards interagency coordination.
Speakers
Linda E. Horner, Acting Senior Lead Administrative Patent Judge, USPTO
Maarika L. Kimbrell, Partner, Morgan Lewis
George O’Brien, Partner, Mayer Brown LLP
Arti Rai, Elvin R. Latty Professor of Law and Faculty Director, The Center for Innovation Policy, Duke Law
Jay Sitlani, Regulatory Counsel, Office of Regulatory Policy, FDA
Moderated by Brian J. Malkin, Associate General Counsel, TEVA Pharmaceuticals USA, Inc
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.